This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


The Treatment of Psychotic Depression

William Coryell, M.D.

Published: April 1, 1998

Article Abstract

Psychotic depression is marked by increased severity, longer episodes, greater incapacity, and alower likelihood of placebo response. Psychotic features often recur in subsequent episodes andinterepisode intervals are shorter when psychotic features have been previously present. Among thetreatment options for psychotic depression, electroconvulsive therapy is particularly effective. Conventionalpharmacotherapy consists of tricyclic antidepressants combined with antipsychotics; recoverywith tricyclic antidepressant monotherapy is less likely. Serotonin selective reuptake inhibitorsmay prove useful but the relevant literature is scant. Pharmacokinetic interactions are likely in combinationtreatment, as are side effects that may mimic the underlying condition. Little is known regardingthe importance of antipsychotics to maintenance therapy.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 59

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...